Jiangsu Lianhuan Pharmaceutical Co.,Ltd. announced that the 1st session of the 6th directorate meeting on March 30, 2015, which discussed and approved issues including the proposal of electing Yao Xingtian as Chairman of 6th Directorate, the issue of appointing Qian Ni as General Manager and the issue of appointing Pan Heping Secretary to Directorate and Yu Baochang as Representative of Securities Affairs.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.27 CNY | -0.12% | -0.12% | -25.76% |
05/06 | China Approves Lianhuan Pharma's Prostate Cancer Tablets | MT |
29/04 | Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-25.76% | 325M | |
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |
- Stock Market
- Equities
- 600513 Stock
- News Jiangsu Lianhuan Pharmaceutical Co., Ltd.
- Jiangsu Lianhuan Pharmaceutical Co.,Ltd. Announces Management and Board Appointments